1.7690
+0.1990
+(12.68%)
At close: January 24 at 3:59:53 PM EST
1.7000
-0.07
(-3.90%)
After hours: January 24 at 6:56:32 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-3,096.0000
-2,851.0000
-2,242.0000
-2,242.0000
Investing Cash Flow
3.0000
-15.0000
-349.0000
-349.0000
Financing Cash Flow
5,560.0000
2,865.0000
2,547.0000
2,547.0000
End Cash Position
2,668.0000
1.0000
2.0000
2.0000
Capital Expenditure
--
-18.0000
-276.0000
-276.0000
Issuance of Debt
1,834.0000
2,865.0000
2,547.0000
2,547.0000
Free Cash Flow
-3,096.0000
-2,869.0000
-2,518.0000
-2,518.0000
12/31/2021 - 9/16/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ESLA Estrella Immunopharma, Inc.
1.1300
0.00%
KTTA Pasithea Therapeutics Corp.
2.4400
-2.40%
KLTO Klotho Neurosciences, Inc.
0.4201
-4.44%
IPSC Century Therapeutics, Inc.
0.9000
-1.11%
IMRN Immuron Limited
2.0000
-7.83%
GLTO Galecto, Inc.
5.62
+3.09%
IZTC Invizyne Technologies, Inc.
13.45
+13.12%
THAR Tharimmune, Inc.
2.0700
-2.36%
VBIZF Viva Biotech Holdings
0.0950
0.00%
LYTIX.OL Lytix Biopharma AS
5.34
-2.55%